Almeida LFC de, Silva LFL da, Gouveia M, Ernst B, Silva JL da, Melo AC de, et al. CDK4/6 inhibitor plus endocrine therapy after progression on CDK4/6 inhibition in HR+/HER2- advanced breast cancer: a systematic review and meta-analysis (ReIGNITE study). MAST [Internet]. 2026 Feb. 24 [cited 2026 May 1];35(suppl.1). Available from: https://mastology.org/journal/article/view/1171